Antitumor Research on Artemisinin and Its Bioactive Derivatives

75Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficiency have been discovered. Many researches indicated that artemisinin-related compounds have cytotoxic effects against a variety of cancer cells through pleiotropic effects, including inhibiting the proliferation of tumor cells, promoting apoptosis, inducing cell cycle arrest, disrupting cancer invasion and metastasis, preventing angiogenesis, mediating the tumor-related signaling pathways, and regulating tumor microenvironment. More importantly, artemisinins demonstrated minor side effects to normal cells and manifested the ability to overcome multidrug-resistance which is widely observed in cancer patients. Therefore, we concentrated on the new advances and development of artemisinin and its derivatives as potential antitumor agents in recent 5 years. It is our hope that this review could be helpful for further exploration of novel artemisinin-related antitumor agents. Graphical Abstract: [Figure not available: see fulltext.].

Cite

CITATION STYLE

APA

Zhang, Y., Xu, G., Zhang, S., Wang, D., Saravana Prabha, P., & Zuo, Z. (2018, August 1). Antitumor Research on Artemisinin and Its Bioactive Derivatives. Natural Products and Bioprospecting. Springer. https://doi.org/10.1007/s13659-018-0162-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free